Ascendis Pharma As Stock Price History
ASND Stock | USD 136.00 0.32 0.23% |
Below is the normalized historical share price chart for Ascendis Pharma AS extending back to January 28, 2015. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Ascendis Pharma stands at 136.00, as last reported on the 29th of November, with the highest price reaching 136.47 and the lowest price hitting 132.39 during the day.
If you're considering investing in Ascendis Stock, it is important to understand the factors that can impact its price. At this point, Ascendis Pharma is very steady. Ascendis Pharma AS secures Sharpe Ratio (or Efficiency) of 0.0219, which signifies that the company had a 0.0219% return per unit of standard deviation over the last 3 months. We have found twenty-nine technical indicators for Ascendis Pharma AS, which you can use to evaluate the volatility of the firm. Please confirm Ascendis Pharma's risk adjusted performance of 0.0136, and Mean Deviation of 2.1 to double-check if the risk estimate we provide is consistent with the expected return of 0.074%.
At present, Ascendis Pharma's Capital Stock is projected to increase significantly based on the last few years of reporting. The current year's Stock Based Compensation is expected to grow to about 70 M, whereas Common Stock Total Equity is forecasted to decline to about 4.2 M. . The current year's Price Earnings To Growth Ratio is expected to grow to 0.79, whereas Price To Sales Ratio is forecasted to decline to 22.84. Ascendis Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 28th of January 2015 | 200 Day MA 136.6051 | 50 Day MA 132.7972 | Beta 0.654 |
Ascendis |
Sharpe Ratio = 0.0219
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | ASND | Huge Risk |
Negative Returns |
Estimated Market Risk
3.39 actual daily | 30 70% of assets are more volatile |
Expected Return
0.07 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
0.02 actual daily | 1 99% of assets perform better |
Based on monthly moving average Ascendis Pharma is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Ascendis Pharma by adding it to a well-diversified portfolio.
Price Book 14.5547 | Enterprise Value Ebitda (20.75) | Price Sales 25.6471 | Shares Float 56.9 M | Wall Street Target Price 181.9796 |
Ascendis Pharma Stock Price History Chart
There are several ways to analyze Ascendis Stock price data. The simplest method is using a basic Ascendis candlestick price chart, which shows Ascendis Pharma price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | September 19, 2024 | 153.43 |
Lowest Price | September 11, 2024 | 112.93 |
Ascendis Pharma November 29, 2024 Stock Price Synopsis
Various analyses of Ascendis Pharma's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Ascendis Stock. It can be used to describe the percentage change in the price of Ascendis Pharma from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Ascendis Stock.Ascendis Pharma Price Action Indicator | 1.41 | |
Ascendis Pharma Price Daily Balance Of Power | (0.08) | |
Ascendis Pharma Price Rate Of Daily Change | 1.00 |
Ascendis Pharma November 29, 2024 Stock Price Analysis
Ascendis Stock Price History Data
The price series of Ascendis Pharma for the period between Sat, Aug 31, 2024 and Fri, Nov 29, 2024 has a statistical range of 40.5 with a coefficient of variation of 7.54. The prices are distributed with arithmetic mean of 131.61. The median price for the last 90 days is 129.36.Open | High | Low | Close | Volume | ||
11/29/2024 | 136.32 | 136.47 | 132.39 | 136.00 | ||
11/29/2024 | 136.32 | 136.47 | 132.39 | 136.00 | ||
11/27/2024 | 134.54 | 136.47 | 132.39 | 136.32 | 355,486 | |
11/26/2024 | 131.42 | 134.71 | 128.63 | 134.60 | 508,125 | |
11/25/2024 | 131.57 | 133.10 | 129.42 | 130.85 | 563,814 | |
11/22/2024 | 124.22 | 130.28 | 122.64 | 129.81 | 639,853 | |
11/21/2024 | 123.45 | 124.63 | 122.43 | 122.64 | 282,569 | |
11/20/2024 | 124.44 | 125.52 | 122.31 | 124.38 | 304,170 | |
11/19/2024 | 120.11 | 125.06 | 119.09 | 124.44 | 714,101 | |
11/18/2024 | 127.34 | 127.34 | 120.73 | 122.00 | 611,083 | |
11/15/2024 | 118.98 | 133.00 | 118.05 | 126.51 | 1,448,850 | |
11/14/2024 | 126.10 | 127.56 | 124.20 | 124.28 | 975,053 | |
11/13/2024 | 128.50 | 129.86 | 125.15 | 126.03 | 594,030 | |
11/12/2024 | 127.39 | 129.51 | 125.40 | 127.67 | 417,745 | |
11/11/2024 | 124.83 | 129.81 | 124.45 | 128.40 | 301,243 | |
11/08/2024 | 127.40 | 128.20 | 124.11 | 124.33 | 459,304 | |
11/07/2024 | 129.28 | 129.28 | 126.26 | 126.55 | 266,595 | |
11/06/2024 | 130.50 | 132.46 | 126.71 | 129.36 | 445,441 | |
11/05/2024 | 124.52 | 129.31 | 122.13 | 128.13 | 282,035 | |
11/04/2024 | 127.20 | 129.17 | 123.03 | 125.77 | 486,062 | |
11/01/2024 | 124.04 | 125.94 | 121.51 | 125.28 | 389,318 | |
10/31/2024 | 121.40 | 124.66 | 120.77 | 122.82 | 344,925 | |
10/30/2024 | 124.92 | 126.81 | 122.50 | 122.80 | 379,144 | |
10/29/2024 | 129.56 | 129.69 | 124.02 | 126.77 | 317,443 | |
10/28/2024 | 131.25 | 133.97 | 129.14 | 129.44 | 248,979 | |
10/25/2024 | 129.93 | 131.42 | 129.17 | 130.32 | 176,662 | |
10/24/2024 | 128.00 | 130.79 | 128.00 | 129.81 | 205,811 | |
10/23/2024 | 128.73 | 130.05 | 126.44 | 127.69 | 286,080 | |
10/22/2024 | 127.36 | 129.95 | 126.02 | 129.07 | 150,588 | |
10/21/2024 | 130.44 | 130.66 | 125.59 | 128.66 | 271,597 | |
10/18/2024 | 127.70 | 131.89 | 126.59 | 129.90 | 381,555 | |
10/17/2024 | 129.52 | 130.00 | 126.00 | 126.66 | 464,806 | |
10/16/2024 | 127.49 | 132.63 | 127.47 | 130.31 | 475,149 | |
10/15/2024 | 128.08 | 128.37 | 125.40 | 127.30 | 282,564 | |
10/14/2024 | 128.63 | 129.68 | 128.00 | 128.46 | 606,660 | |
10/11/2024 | 129.74 | 130.52 | 128.63 | 128.87 | 534,568 | |
10/10/2024 | 127.55 | 130.79 | 127.55 | 130.33 | 496,519 | |
10/09/2024 | 132.00 | 132.00 | 127.11 | 129.30 | 559,821 | |
10/08/2024 | 138.95 | 143.53 | 131.73 | 132.05 | 976,951 | |
10/07/2024 | 141.07 | 142.07 | 139.00 | 139.14 | 222,996 | |
10/04/2024 | 141.65 | 142.80 | 139.56 | 142.67 | 340,459 | |
10/03/2024 | 145.20 | 146.23 | 140.54 | 140.95 | 411,702 | |
10/02/2024 | 146.47 | 147.96 | 144.88 | 146.29 | 564,971 | |
10/01/2024 | 149.31 | 149.31 | 144.12 | 146.60 | 376,831 | |
09/30/2024 | 143.69 | 149.67 | 143.12 | 149.31 | 541,362 | |
09/27/2024 | 147.01 | 148.31 | 142.98 | 144.62 | 516,852 | |
09/26/2024 | 147.64 | 147.64 | 144.43 | 147.36 | 327,798 | |
09/25/2024 | 144.78 | 149.56 | 144.73 | 146.27 | 314,887 | |
09/24/2024 | 145.98 | 147.58 | 143.98 | 144.89 | 519,916 | |
09/23/2024 | 151.48 | 151.87 | 145.72 | 146.60 | 761,403 | |
09/20/2024 | 153.75 | 155.53 | 150.85 | 151.26 | 1,707,997 | |
09/19/2024 | 151.00 | 154.81 | 149.26 | 153.43 | 1,222,686 | |
09/18/2024 | 146.59 | 150.43 | 145.77 | 148.88 | 885,209 | |
09/17/2024 | 140.24 | 148.92 | 138.82 | 146.59 | 1,993,512 | |
09/16/2024 | 139.65 | 145.00 | 137.75 | 139.57 | 2,913,024 | |
09/13/2024 | 116.29 | 119.49 | 114.53 | 119.22 | 589,551 | |
09/12/2024 | 112.93 | 116.90 | 111.09 | 113.81 | 2,294,993 | |
09/11/2024 | 114.19 | 116.11 | 111.23 | 112.93 | 758,970 | |
09/10/2024 | 116.03 | 119.01 | 113.03 | 114.76 | 696,032 | |
09/09/2024 | 119.06 | 119.74 | 116.52 | 116.84 | 1,050,293 | |
09/06/2024 | 118.99 | 121.25 | 117.40 | 119.15 | 625,893 |
About Ascendis Pharma Stock history
Ascendis Pharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Ascendis is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Ascendis Pharma AS will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Ascendis Pharma stock prices may prove useful in developing a viable investing in Ascendis Pharma
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 56.3 M | 39.2 M | |
Net Loss | -524.9 M | -498.6 M |
Ascendis Pharma Stock Technical Analysis
Ascendis Pharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Equity Search Now
Equity SearchSearch for actively traded equities including funds and ETFs from over 30 global markets |
All Next | Launch Module |
Ascendis Pharma Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Ascendis Pharma's price direction in advance. Along with the technical and fundamental analysis of Ascendis Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Ascendis to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.0136 | |||
Jensen Alpha | (0.08) | |||
Total Risk Alpha | (0.49) | |||
Sortino Ratio | (0.04) | |||
Treynor Ratio | 0.0185 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Complementary Tools for Ascendis Stock analysis
When running Ascendis Pharma's price analysis, check to measure Ascendis Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ascendis Pharma is operating at the current time. Most of Ascendis Pharma's value examination focuses on studying past and present price action to predict the probability of Ascendis Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ascendis Pharma's price. Additionally, you may evaluate how the addition of Ascendis Pharma to your portfolios can decrease your overall portfolio volatility.
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |